Actual Medicinal Product (AMP) Haloperidol 1.5mg tablets (Crescent Pharma Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Store in airtight containers. Protect from light

Provenance

This compatibility recommendation is derived from Haloperidol 1.5mg tablets (Teva UK Ltd).

Generic
Haloperidol
Formulation
Haloperidol 1.5mg tablets
  • Haloperidol
    • Haloperidol 1.5mg tablets

      • Haloperidol 1.5mg tablets (Crescent Pharma Ltd)